3 Warren Buffett Stocks I'd Buy Without Any Hesitation

66
Comment
Favorite

3 Warren Buffett Stocks I'd Buy Without Any Hesitation

Motley Fool2022-03-28

I'll admit that I've sometimes succumbed to "analysis paralysis" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

ramius75
·2022-03-30
🚀🚀🚀
Reply
Like
Report
KYHBKO
·2022-03-29
all the more, we should add $Berkshire Hathaway(BRK.B)$to our portfolio holding. then, we can own all these good stocks. though it is not structured like an ETF, it is definitely one of the best performing stock ownership of multiple assets under one singular holding.
Reply
17
Report
Tanyl
·2022-03-28
Buy ABBV in option
Reply
1
Report
Tanyl
·2022-03-28
Follow Buffet
Reply
1
Report
StarGalaxy
·2022-03-28
Ok
Reply
Like
Report
Anzygart
·2022-03-28
Ok
Reply
2
Report
haoren
·2022-03-28
Nice
Reply
1
Report
atsc
·2022-03-28
Nice
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2222860659?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-28 20:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2222860659","market":"us","top_or_hot":-1,"title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","media":"Motley Fool","content":"<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4566","symbol_name":"资本集团","start_time":0,"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","article_id":"2222860659","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","pubTimestamp":1648471391,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"These stocks offer a lot to like.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4566":"资本集团","BK4527":"明星科技股","ABBV":"艾伯维公司","BK4550":"红杉资本持仓","BK4176":"多领域控股","BK4551":"寇图资本持仓","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4561":"索罗斯持仓","BK4538":"云计算","BK4535":"淡马锡持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","AMZN":"亚马逊","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4503":"景林资产持仓","BK4581":"高盛持仓","BK4524":"宅经济概念","BK4579":"人工智能","BRK.B":"伯克希尔B","BRK.A":"伯克希尔","BK4559":"巴菲特持仓","BK4122":"互联网与直销零售"},"translate_title":"我会毫不犹豫地购买沃伦·巴菲特的3只股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMZN":0.9,"BRK.B":0.9,"BRK.A":0.9,"ABBV":0.9},"content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9019617904,"gmtCreate":1648595966393,"gmtModify":1676534358749,"author":{"id":"3586470645934044","authorId":"3586470645934044","name":"ramius75","avatar":"https://community-static.tradeup.com/news/c4c299991e47de2cfc27ff1e679cc5ee","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1},"htmlText":"🚀🚀🚀","listText":"🚀🚀🚀","text":"🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9019617904","repostId":2222860659,"repostType":2,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9019082118,"gmtCreate":1648504707473,"gmtModify":1676534344971,"author":{"id":"3574381076586256","authorId":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"all the more, we should add&nbsp;<a href=\"https://ttm.financial/S/BRK.B\">$Berkshire Hathaway(BRK.B)$</a>to our portfolio holding. then, we can own all these good stocks.&nbsp;though it is not structured like an ETF, it is definitely one of the best performing stock ownership of multiple assets under one singular&nbsp;holding.&nbsp;","listText":"all the more, we should add&nbsp;<a href=\"https://ttm.financial/S/BRK.B\">$Berkshire Hathaway(BRK.B)$</a>to our portfolio holding. then, we can own all these good stocks.&nbsp;though it is not structured like an ETF, it is definitely one of the best performing stock ownership of multiple assets under one singular&nbsp;holding.&nbsp;","text":"all the more, we should add $Berkshire Hathaway(BRK.B)$to our portfolio holding. then, we can own all these good stocks. though it is not structured like an ETF, it is definitely one of the best performing stock ownership of multiple assets under one singular holding.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9019082118","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010745898,"gmtCreate":1648478512747,"gmtModify":1676534342990,"author":{"id":"4087109808120260","authorId":"4087109808120260","name":"Tanyl","avatar":"https://static.tigerbbs.com/174329973340cf0f5b68791ee5b08afd","vip":1,"crmLevel":7,"crmLevelSwitch":1},"htmlText":"Buy ABBV in option","listText":"Buy ABBV in option","text":"Buy ABBV in option","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010745898","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010742869,"gmtCreate":1648478405810,"gmtModify":1676534342976,"author":{"id":"4087109808120260","authorId":"4087109808120260","name":"Tanyl","avatar":"https://static.tigerbbs.com/174329973340cf0f5b68791ee5b08afd","vip":1,"crmLevel":7,"crmLevelSwitch":1},"htmlText":"Follow Buffet&nbsp;","listText":"Follow Buffet&nbsp;","text":"Follow Buffet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010742869","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010756136,"gmtCreate":1648476742412,"gmtModify":1676534342725,"author":{"id":"4090381790893340","authorId":"4090381790893340","name":"StarGalaxy","avatar":"https://static.tigerbbs.com/49916fa198da24e2605abf24a28d23d2","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010756136","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010724855,"gmtCreate":1648476055132,"gmtModify":1676534342569,"author":{"id":"4087708380401170","authorId":"4087708380401170","name":"Anzygart","avatar":"https://static.tigerbbs.com/5255e6a87df642eff53b65456895ac13","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010724855","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010761054,"gmtCreate":1648474019007,"gmtModify":1676534342144,"author":{"id":"3581803494981906","authorId":"3581803494981906","name":"haoren","avatar":"https://static.tigerbbs.com/959cadb42575ede705b330aa58d68a63","vip":1,"crmLevel":6,"crmLevelSwitch":1},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010761054","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010763134,"gmtCreate":1648473933038,"gmtModify":1676534342129,"author":{"id":"3562791266647459","authorId":"3562791266647459","name":"atsc","avatar":"https://static.tigerbbs.com/9ec47b1c36e59ba1ef8caac8ab619319","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":1},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010763134","repostId":2222860659,"repostType":4,"repost":{"id":"2222860659","pubTimestamp":1648471391,"share":"https://www.laohu8.com/m/news/2222860659?lang=&edition=full","pubTime":"2022-03-28 20:43","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2222860659","media":"Motley Fool","summary":"These stocks offer a lot to like.","content":"<html><head></head><body><p>I&#39;ll admit that I&#39;ve sometimes succumbed to &#34;analysis paralysis&#34; in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.</p><p>With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team &#34;find little that excites us.&#34;</p><p>However, there are some stocks that I think shouldn&#39;t need over-analysis before buying. A few of them are even in Buffett&#39;s investment portfolio. Here are three Buffett stocks I&#39;d buy without any hesitation.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F671140%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: The Motley Fool.</span></p><h2>1. Berkshire Hathaway</h2><p><b>Berkshire Hathaway</b> stands at the top of my list. I don&#39;t include it merely because it&#39;s where most of Buffett&#39;s own money is invested, though. My take on Berkshire is that it&#39;s almost like an exchange-traded fund (<a href=\"https://laohu8.com/S/PSFF\">Pacer Swan SOS Fund of Funds ETF|ETF</a>). You can get a diversified basket of stocks in <a href=\"https://laohu8.com/S/AONE.U\">one</a> fell swoop. That diversification can lower your risk.</p><p>When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.</p><p>I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire&#39;s horizons.</p><p>Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the <b>S&amp;P 500 index</b> over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.</p><h2>2. Amazon.com</h2><p>Buffett was really late to the part in buying <b>Amazon.com</b> for Berkshire&#39;s portfolio. However, the old saying that &#34;better late than never&#34; is right in this case. I wouldn&#39;t have to think very long before buying the stock now.</p><p>For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.</p><p>However, Amazon&#39;s biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon&#39;s e-commerce business.</p><p>I also love how Amazon continually looks to expand into new markets. The company&#39;s recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.</p><h2>3. AbbVie</h2><p>Buffett sold some of Berkshire&#39;s stake in <b>AbbVie</b> in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.</p><p>I think that AbbVie&#39;s long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie&#39;s management team says it expects to quickly return to solid growth. I believe the team is right.</p><p>AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.</p><p>Don&#39;t forget AbbVie&#39;s juicy dividend. The company&#39;s dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BK4548":"巴美列捷福持仓","AMZN":"亚马逊","BRK.B":"伯克希尔B","BK4176":"多领域控股","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","ABBV":"艾伯维公司","BK4561":"索罗斯持仓","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/03/28/3-warren-buffett-stocks-id-buy-without-any-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222860659","content_text":"I'll admit that I've sometimes succumbed to \"analysis paralysis\" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself acknowledged recently that he and his investing team \"find little that excites us.\"However, there are some stocks that I think shouldn't need over-analysis before buying. A few of them are even in Buffett's investment portfolio. Here are three Buffett stocks I'd buy without any hesitation.Image source: The Motley Fool.1. Berkshire HathawayBerkshire Hathaway stands at the top of my list. I don't include it merely because it's where most of Buffett's own money is invested, though. My take on Berkshire is that it's almost like an exchange-traded fund (Pacer Swan SOS Fund of Funds ETF|ETF). You can get a diversified basket of stocks in one fell swoop. That diversification can lower your risk.When you buy Berkshire, you become a part-owner in more than 60 businesses that are part of the Berkshire family. These include businesses such as Geico, Duracell, and railroad giant BNSF. But you also get a position in the 40 or so stocks that Berkshire owns.I like that purchasing shares of Berkshire gains access to two of the greatest investing minds of all time -- Buffett and his longtime business partner Charlie Munger. The company also has two other solid investment managers (Todd Combs and Ted Weschler) who have expanded Berkshire's horizons.Last, but certainly not least, Berkshire has proved to be a winner. The stock has outperformed the S&P 500 index over the past one, three, and 10 years. I expect that Berkshire will keep up its winning ways.2. Amazon.comBuffett was really late to the part in buying Amazon.com for Berkshire's portfolio. However, the old saying that \"better late than never\" is right in this case. I wouldn't have to think very long before buying the stock now.For one thing, e-commerce still has a lot of room to run. Last year, e-commerce sales in the U.S. accounted for only 13.2% of total retail sales. I fully expect that percentage to grow, with Amazon leading the way.However, Amazon's biggest growth driver is Amazon Web Services (AWS). Sales for AWS soared nearly 40% year over year in the fourth quarter of 2021. And the cloud unit is a lot more profitable than Amazon's e-commerce business.I also love how Amazon continually looks to expand into new markets. The company's recent acquisition of MGM makes its Prime Video service even more formidable in streaming. Amazon is also a rising force in healthcare and self-driving car technology. All of these are areas that should grow tremendously in the future.3. AbbVieBuffett sold some of Berkshire's stake in AbbVie in the fourth quarter of 2021. That proved to be a mistake -- at least over the short term. The pharma stock has jumped 19% year to date while many stocks have floundered.I think that AbbVie's long-term prospects look good, too. Sure, the company faces the loss of U.S. exclusivity next year for its top-selling drug, Humira. However, AbbVie's management team says it expects to quickly return to solid growth. I believe the team is right.AbbVie already has two successors to Humira on the market. Rinvoq and Skyrizi should help offset much of the anticipated sales declines on the way for Humira. The company also has several other growth drivers, including blood cancer drug Venclexta and antipsychotic drug Vraylar.Don't forget AbbVie's juicy dividend. The company's dividend currently yields 3.5%. AbbVie is a Dividend King with 50 consecutive years of dividend increases. I look for the company to keep that streak going with more dividend increases in the future.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":66,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}